Abstract
CFTR is unique among ABC transporters as the only one functioning as an ion channel and from a human health perspective because mutations in its gene cause cystic fibrosis. Although considerable advances have been made towards understanding CFTR’s mechanism of action and the impact of mutations, the lack of a high-resolution 3D structure has hindered progress. The large multi-domain membrane glycoprotein is normally present at low copy number and when over expressed at high levels it aggregates strongly, limiting the production of stable mono-disperse preparations. While the reasons for the strong self-association are not fully understood, its relatively low thermal stability seems likely to be one. The major CF causing mutation, ΔF508, renders the protein very thermally unstable and therefore a great deal of attention has been paid to this property of CFTR. Multiple second site mutations of CFTR in NBD1 where F508 normally resides and small molecule binders of the domain increase the thermal stability of the mutant. These manipulations also stabilize the wild-type protein. Here we have applied ΔF508-stabilizing changes and other modifications to generate wild-type constructs that express at much higher levels in scaled-up suspension cultures of mammalian cells. After purification and reconstitution into liposomes these proteins are active in a locked-open conformation at temperatures as high as 50°C and remain monodisperse at 4°C in detergent or lipid for at least a week. The availability of adequate amounts of these and related stable active preparations of homogeneous CFTR will enable stalled structural and ligand binding studies to proceed.
Keywords: membrane protein, ion channel, CFTR, ABC protein, protein thermal stability, cystic fibrosis
Introduction
The CFTR protein product of the gene mutated in patients with cystic fibrosis is unique among members of the large ABC protein family, acting as an ion channel rather than a transporter[1]. While the common fold of the CFTR channel and ABC exporters is apparent, the detailed structural differences that distinguish them functionally are not. This uncertainty is primarily due to the fact that although 3D structures of several exporters have been determined[2–9], CFTR has remained refractory to structure determination at high resolution because of difficulties in obtaining homogeneous active protein for analyses. The channel is normally expressed at low levels in epithelial cells and there is no rich natural source. When heterologously over expressed the protein self-associates strongly and has limited detergent solubility[10]. This behavior is exacerbated as levels of expression are increased. Although some proportion of the very large number of channel proteins that can be expressed in bacculovirus infected insect cells exhibit activity[11], the bulk of the protein is soluble only in strong denaturing detergents[12, 13]. This poor solubility, in mild crystallization-compatible detergents, is shared by the protein expressed in Saccharomyces cerevisiae[14] in which the protein is retained in the endoplasmic reticulum[15]. In mammalian cell systems, CFTR expression and functional characterization in membranes has been performed using CHO[16, 17], BHK[18, 19], and HEK-293 cells[20]. CFTR could be readily solubilized from membranes of these cells by mild detergents including dodecyl-maltoside, neo-pentylmaltosides, and others enabling purification of small amounts suitable for low resolution structural analysis by electron microscopy[19–21].
The goal of the current work was to generate milligram amounts of homogeneous human CFTR protein that is active, thermally stable and in a restricted conformational state. This objective was achieved employing a strategy in which the thermal stability of modified constructs was first evaluated functionally in membranes from rapidly generated small cultures prior to scaling-up for expression in large mammalian cell suspension cultures for purification and reconstitution.
Materials and Methods
Mammalian cell expression of CFTR
Wild-type and mutated CFTR cDNA constructs were generated in the pNUT selectable expression plasmid and transfected into BHK-21 cells as previously described[22]. Individual colonies surviving methotrexate selection were expanded on the surfaces of standard cell culture flasks in DMEM/F12 medium supplemented with 5% FBS and containing 500 μM methotrexate. These adherent cells were adapted to growth in suspension by first gradually weaning them from this medium to SFM II 293s suspension medium (Invitrogen) supplemented with 2% FBS, 2x glutamine, 250μM methotrexate. Once cells were adapted to the suspension medium, they were switched from normal tissue culture treated plastic dishes to non-tissue culture treated ones and passaged until the majority of cells in the culture grew as free floating clumps rather than loosely attached to the substrate. Once cells were actively growing in suspension, they were switched to standard spinner cultures for expansion. Cells were further expanded until cell numbers reached ~2x106/ml. Cells were maintained in humidified incubators at 37°C with 5% CO2 during the adaptation process. When the spinner cell culture volume reached 500 ml, the cultures were expanded to 700 ml and transferred to 2L square PETG plastic medium bottles (Fisher). At this point the cultures were transferred to a New Brunswick Scientific model I2500 floor shaker incubator and maintained at 37°C without CO2 at a rotation rate of 120 rpm. Cultures were maintained at a minimum cell density of 2x106 cells/ml with the caps slightly loosened to allow for air exchange. Cultures could be maintained at cell densities as high as 5x106 cells/ ml, however culture health was optimal at 3 –4x106 cells/ml. The levels of CFTR expression at each stage were monitored by Western blotting of whole cell lysates and small-scale membrane preparations using methods described earlier[23]. The relative amounts of mature (diffuse major, more slowly migrating band containing complex N-linked oligosaccharide chains and immature (sharp minor, more rapidly migrating band with core N-linked chains) CFTR forms were measured with an Odyssey Imaging system (Li-Cor Bioscience, Lincoln, Nebraska). The immature endoplasmic reticulum located biosynthetic intermediate is removed during the differential detergent solubilization (see below) and is not purified.
Isolation of microsomal membranes
Typically lots of 8–10 bottles, each containing700 ml cultures at ~3.5 – 4x106 cells per ml were harvested by centrifugation at 2500 rpm using a GS3 rotor and washed with cold PBS yielding approximately 80 ml of packed cells. After the PBS wash, cells were resuspended with 10 times the cell pellet volume in ice cold lysis buffer (50 mMTris-HCl pH 7.4, 1 mM EDTA) containing 3X concentrated protease inhibitors: (Leupeptin (RPI) 3.0 μg/ml, Aprotinin (RPI) 6.0 μg/ml, Pefabloc (RPI) 150 μg/ml, Benzamidine (Fisher) 36 μg/ml, E64 (AG Scientific) 10.5 μg/ml. The resuspended cells were incubated on ice for 10 minutes then disrupted with 5 strokes of a 100 ml Dounce homogenizer. Sucrose buffer (25 ml of 1.5 M sucrose, 50 mM Tris pH 7.2) was added to the homogenate and mixed with 2 more strokes. Unbroken cells and cell debris were removed by centrifugation at 5000 rpm in a GS3 rotor. The crude membranes were collected by centrifugation of the GS3 supernatant in a SW28 rotor at 26,500 rpm for 30 minutes at 4°C. The membrane pellets were collected and resuspended in buffer A (see below) containing 2X protease inhibitors). Membranes were stored at −80°C prior to solubilization. Protein concentrations were measured using bicinchoninic acid assay (BCA reagent from Pierce Thermo Scientific).
CFTR purification
Buffer constituents: Buffer A; 40 mMTris-HCl, pH 7.4; 0.5 M NaCl; 0.1M arginine; 20% glycerol. Buffer B; 50 mM Na-phosphate, pH 7.6; 0.5 M NaCl; 0.1 M arginine; 15% glycerol. Buffer C; 40 mMTris-HCl, pH 7.4; 0.15 M NaCl; 10% glycerol. All buffers contained a protease inhibitor cocktail (benzamidine at 120 μg/ml, E-64 [trans-epoxysuccinyl-L-leucylamido-(4-guanido)butane] at 3.5 μg/ml, aprotinin at 2 μg/ml, leupeptin at 1 μg/ml and Pefabloc at 50 μg/ml) and 5mM Mg-ATP.
Membranes containing CFTR were resuspended in buffer A containing 0.01% DMNG (Decyl Maltose Neopentyl Glycol; Anatrace), incubated for 15 min at 4°C and centrifuged at 26,000 rpm in an SW-28 Rotor for 35 min. The supernatant was discarded and the pellet was resuspended and solubilized in buffer B containing 1% DMNG. After a 30 minute incubation at 4°C the suspension was centrifuged at 26,000 rpm for 35 minutes. The detergent extract was mixed with Co-Talon resin (Clontech) and gently rotated for 3h at 4°C. The resin was washed with buffer B containing 25 mM imidazole and 0.2% DMNG followed by 50 mM imidazole with 0.1% DMNG. CFTR was eluted with 180mM imidazole in buffer C containing 0.01% DMNG and dialyzed against the same buffer lacking imidazole overnight at4°C. The CFTR eluates were concentrated up to the desired protein concentration using centrifugal filter units with a 150kDa cut off (Pierce Concentrators; Thermo Scientific).
Liposome preparation and CFTR reconstitution
Lipid stock solutions in chloroform were mixed in the desired proportions (DOPE, DOPC, DOPS, Cholesterol; 48:22:12:18) and dried in a rotary evaporator. All manipulations with the lipids were conducted under nitrogen gas. The dried lipids were suspended in buffer C to a final concentration of 20 mg/ml. The lipid suspensions were sonicated with 3 cycles of 5 min each in a water bath sonicator (Avanti) to generate small unilamellar (SUVs) vesicles. The SUV suspension was flash frozen in liquid nitrogen followed by slow thawing at room temperature to fuse the SUVs into large multilamellar vesicles (LMVs) that were kept frozen at −80°C until use.
In preparation for incorporation of CFTR, LMVs (10mg/ml) were extruded through 1000 nm and then 400nm polycarbonate membranes (15 times each) to form Large Uni Lamellar Vesicles (LULVs). These were diluted to 5 mg/ml of lipids in buffer C containing 10 mM Mg-ATP and 20% glycerol to yield final concentrations of MgATP and glycerol of 5 mM and 10%, respectively in the liposome suspension. Liposome destabilization at room temperature by incremental addition of Triton X-100 at 2 min intervals was monitored by measuring the optical density of the suspension at 540 nm. After addition of DTT to a final concentration of 5 mM and protein kinase A to 25 U/ml and incubation for 1 h at 4°C, the purified CFTR protein was mixed with the destabilized liposomes at a 1:50 (w/w) protein to lipid ratio and incubated for 30 min at 4°C with gentle agitation. To remove the detergent and form the proteoliposomes, 3 additions of Bio-Beads SM2 were made at 4 h intervals. Proteoliposomes were separated from the beads by centrifugation at 2000rpm and kept at 4°C until functional analysis.
Single channel analysis
Planar lipid bilayers were formed with a 3:1 mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (Avanti Polar Lipids) as detailed previously[24]. CFTR ion channels were transferred into the preformed lipid bilayer by spontaneous fusion of membrane vesicles containing naturally folded CFTR constructs or proteoliposomes containing purified and reconstituted protein. To maintain uniform orientation and functional activity of CFTR channels transferred into the bilayer, 5 mM MgATP, 50 nM PKA and membrane vesicles or proteoliposomes were added in the cis compartment only. All measurements were done in symmetrical salt solution (300mM Tris–HCl, pH 7.2, 3mM MgCl2 and 1mM EGTA) under voltage-clamp conditions using an Axopatch 200B amplifier. The membrane voltage potential of −75 mV is the difference between cis and trans (ground) compartments. Data analysis was performed as described earlier[25].
Heating and temperature control were established by a temperature control system TC2BIP (Cell Micro Controls, Norfolk, VA, USA) with heating element covering the “trans” compartment outer side surfaces and bottom surface. Because of the bulky “trans” compartment it takes approximately 2–3 minutes to achieve a uniform temperature distribution across all compartments after the first indication of the expected temperature by the local temperature sensor in the chamber. Over the temperature range from +20°C to +40°C the wild type CFTR single channel has a well-resolved open state with linear dependence between open state conductance at −75 mV and the holding temperature as found previously[26]. We use this linear relationship as an intrinsic thermometer to define the real temperature in the vicinity of the channel during the non-stationary temperature RAMP experiments where temperature distribution across the experimental chamber is not uniform. Therefore in all experiments under non-stationary temperature conditions the actual temperature was indicated by the single channel conductance rather than by the local thermometer reading. We consider the thermal stability of wild type CFTR function in terms of its ability to support single channel function with stable open state conductance for the next 5 minutes after initial 5 minute incubation at the temperature of interest. The inactivation temperature (Ti) was defined as the temperature 1°C above the highest temperature with a stable open state during the total 10 min period.
Results
Thermal sensitivity of wild-type CFTR channels
The low thermal stability of the mutant form of CFTR (ΔF508) that causes most cystic fibrosis has been extensively studied[27–33] because of the obvious clinical relevance. Extensive biophysical studies of the isolated domain (NBD1) in which F508 normally resides showed that its thermal melting temperature (Tm) was reduced ~6°C compared to that of the wild-type domain[30]. Functionally the full-length ΔF508 protein becomes inactive at temperatures in the 30°C range and above[28, 29]. While the wild-type protein is of course active at physiological temperature and to at least 40°C[26], higher temperatures have not been investigated. To pursue the hypothesis that limited thermal stability may be a major factor contributing to difficulties in generating well-behaved protein for structural studies we assessed the influence of higher temperatures on channel function. After prolonged uniform gating at 40°C (Fig.1a, upper tracing) temperature was ramped up to 45°C at a rate of 1°C /min (middle tracing). Gating appeared to become somewhat less uniform soon above 40°C followed by a progressive increase in variability and the appearance of sub-conductance states. After approximately 1 min at 45°C there was an abrupt loss of near-full conductance gating. This real time transition is shown in expanded scale in the lower tracing. Not surprisingly, neither the precise transition temperature nor the time at that temperature before the transition occurred is identical in repeated single channel tracings. However, there was a high degree of overall reproducibility and the inactivation temperature (Ti) varied from 43°C to 45°C depending on the rate of temperature increase during the ramps. Having established the critical temperature range, we followed single channel activity at constant temperatures around this range (Fig. 1b). Each tracing represents gating over a period of five minutes after a previous five minute equilibration of the chamber to each of the temperatures indicated. Stable open states were maintained over the entire period at temperatures up to 43°C. At 44°C normal gating continued for only approximately one minute after the pre-equilibration and did not appear at all at 45°C. Thus, defined as the temperature 1°C above the highest temperature with a stable open state, we conclude that the Ti of wild-type CFTR under these conditions is 44°C. This provides a reference point for comparison of the thermal sensitivity of stabilized CFTR variants.
Expression and function of stabilized CFTR constructs
Guided by modifications that we previously found to greatly improve the stability, maturation and function of ΔF508 CFTR[24, 32, 33], we made the same mutations in the wild-type and assessed their influence on expression and channel function in BHK cells. As seen in Fig. 2a the “2PT” variant with NBD1 mutations S492P, A534P and I539T and the ΔRI variant, from which the Regulatory Insertion (residues 404 – 435) was deleted both increased expression levels substantially compared to the wild type. In Fig. 2b it can be seen that RI removal had little influence on open probability (second tracing), consistent with an earlier study[33]. Channel open probability was substantially reduced in 2PT due to the introduction of the two prolines into the mobile Q loop (S492P) and SDR (A534P) regions of NBD1 (third tracing). Substitution of residue H1402 in NBD2 alone, predicted to participate in and be the “linch-pin” in the NBD2 ATP binding site[34], had little effect on expression levels but increased channel Po to a very high level (fourth tracing). When the two types of NBD1 modification were combined, expression and maturation were greatly increased as observed in the Western blots (Fig. 2a) while channel open probability (fifth tracing) was similar to that of the 2PT variant. When the H1402S mutations was added to the combined NBD1 modifications, the amount of CFTR expressed by the cells (and present in isolated membranes) was increased 3 to 5 fold compared to the wild-type and the mature/immature band intensity ratio as an index of maturation also was elevated (not shown). The channel Po was increased to nearly 1 indicating that the channel was virtually locked open at 37°C.
The thermal stability of the ΔRI/2PT/H1402S channel in isolated microsomal membranes was evaluated and it was found to retain full activity at 45°C for at least 1h (Fig 3, top tracing) and remain active during a temperature ramp from 45°C to 50°C albeit with open state subconductances most evident in the extended lower tracing at 50°C. Thus, the increased amounts of protein expressed and greater thermal stability encouraged us to proceed with purification and characterization of this variant.
Scale-up and purification
We had previously purified small quantities of CFTR expressed in BHK cells grown on the surfaces of tissue culture plates[19]. For production of larger amounts necessary for crystallization trials and other biophysical studies, the cells were adapted to high density suspension culture on a reasonably large-scale, enabling the generation of lots of ~ 5 x 1010 cells as starting material for purification. This number of cells yielded ~ 1g of microsomal membranes from which ~ 2 mg of wild-type and ~ 10 mg of the ΔRI/2PT/H1402S variant could be purified. The purity of these preparations as assessed by SDS-PAGE and their homogeneity on gel filtration in DMNG is shown in Fig. 4. The purified ΔRI/2PT/H1402S protein was highly homogeneous as judged by heavily loaded SDS-PAGE gels (Fig. 4a) and appeared monodisperse in the low concentration of the DMNG (at 3 x CMC) detergent in which it was purified (Fig. 4b). The molecular mass of the major peak was estimated at 320 kDa from multi-angle light scattering analysis (MALS), substantially less than that predicted for a dimer but greater than that of a monomer. This may be due to the detergent micelles binding to monomeric CFTR. The gel filtration profile of the purified ΔRI/2PT/H1402S protein was unaltered after storage at 4°C for at least two weeks and little changed when kept at 16°C for this period of time (data not shown).
Reconstitution and thermal stability of purified CFTR
Efficient reconstitution into liposomes was achieved by fairly standard procedures detailed in Methods (Fig. 4c). In the case of the wild-type protein, when the proteoliposomes were fused with planar bilayers, only very rare channel openings were detected even at the low temperature of 25°C in contrast to the robust gating observed when microsomal vesicles of the cells from which the protein was purified were fused with the bilayer (Fig. 5, left panels). At 30°C with the reconstituted wild-type protein, no full conductance openings, but only the so-called fast flickering mode (ffm), characteristic of disrupted CFTR[24, 33], were detected, whereas with the microsomal vesicles, the Po of wild-type CFTR channels was approximately doubled when the temperature was increased from 25°C to 30°C as expected (Fig. 5, right panels).
In marked contrast to the minimal CFTR channel activity observed with the purified wild-type protein, the purified ΔRI/2PT/H1402S protein was fully active at temperatures of 25, 30 and 37°C with very high open probability in all cases (Fig. 6, left 3 tracings). Indeed this behavior persisted for at least 1 hour even at 45°C (Fig. 6, top right tracing). When temperature was continuously increased further, robust gating continued until 50°C, although with sub-conductance states appearing over this range (Fig. 6, middle right tracing). Nevertheless, stable function in the “locked-open” mode continued for at least ½ hour at 50°C (Fig. 6, lower right tracing). Thus, this highly expressed construct appears to fulfill several criteria required for structural analyses including greatly increased life-time and thermal stability as well as a preferred conformational state in which the channel is locked open. The virtually identical single channel properties of the protein before and after purification and reconstitution are emphasized in Fig. 7. Fusion of proteoliposomes containing the homogeneous protein with the planar bilayer shown in panel (a) resulted in the very rapid appearance of multiple channels (panel b), reflecting the high frequency of active molecules in the population. Individual members of this purified and reconstituted population had the same conductance and open probability as those in the membranes of the cells from which they were obtained (panel c).
Discussion
Limited thermal stability of proteins after removal from their cellular environments often prevents them from remaining soluble and mono-disperse for extended periods so that their inherent properties including three-dimensional structures can be determined. Indeed, low structural stability may make even obtaining these proteins in pure form very difficult because the quality control systems of the cells in which they are expressed recognize them as incompletely or incorrectly folded and degrade them[35]. The proportion of molecules avoiding this fate still may not have achieved a complete fully-folded state and have a strong tendency to associate with self (aggregation) and other proteins during purification steps. These latter problems are further exacerbated in the case of membrane proteins where hydrophobic segments become exposed when extracted from the bilayer with detergents. The presence of inherently disordered regions in proteins also may diminish their overall thermal stability and proteins that must be highly dynamic in the performance of their physiological function require a fine balance between stability and mobility.
The early recognition that wild-type CFTR folds and assembles very inefficiently in cells, with only about 25 –30 % of the nascent polypeptide maturing[36], may reflect the fact that it has difficulty achieving this balance. Attention was further focused on this issue when it was found that the mutation causing most cystic fibrosis, ΔF508, made the protein much more thermally unstable so that virtually none of the mutant polypeptide matured at mammalian physiological temperature[27]. Deletion of F508 from isolated NBD1 reduces its Tm by ~ 6°C[30] and this destabilization is reflected in the function of the full-length mutant channel[30, 32].
The relationship of the functional Ti values we have determined to the gross conformational perturbation of the protein as may be reflected in a cooperative melting transition measured by calorimetry or spectroscopy is not yet known. These values may or may not correspond. The Ti might reflect a more subtle predenaturational change in a structural element that is rate limiting in channel gating, possibly in the pore itself or in a key regulatory site. As discussed extensively by Privalov and colleagues[37, 38] multiple such local unfolding events are likely to occur in large multimeric proteins, possibly gradually, in overlapping stages. Although different CFTR channel sub-conductance states appeared when temperature was continuously increased, the complete loss of activity occurred rather abruptly. Interestingly, the Ti of the wild type channel activity (~44°C) is in the same range as the Tm of isolated NBD1[30]. Although this could be entirely coincidental, the fact that our variants with increased Ti have greater stability and longer lifetime in cells and after purification is consistent with a more global stabilization of the protein. It will now be important to determine Tm values of the purified full-length protein by biophysical methods both before and after reconstitution.
Many second site mutations in NBD1 of ΔF508 CFTR and at least one small molecule promote its conformational maturation[32]. We have found that these effects are not specific to the ΔF508 mutant, however, but also improve the maturation of the wild-type protein. When this set of NBD1 stabilizing mutations were combined with the H1402S substitution in NBD2 the level of mature protein expression in BHK cells increased several fold, enabling purification of milligram quantities of homogeneous protein that remained monodisperse at concentrations > 3 mg/ml in a low concentration of DMNG (3X CMC).
Importantly, this pure protein could be quantitatively incorporated into liposomes in a fully functional state in which it remained for periods longer than two weeks. Thus, the preparation appears to be quantitatively and qualitatively suitable for crystallization trials in detergent or lipid and the structural information that may be obtained will reflect that of an active folded state. With this construct as a platform it may be possible to introduce further modifications that drive the channel to different functional states and then determine the structural differences between them.
Highlights.
Full understanding of the unique ABC ion channel, CFTR awaits high resolution structure determination
Because of its marginal thermodynamic stability, expression and purification in a mono-disperse active form is extremely challenging.
Here we have employed functional assays of channel activity to assess the effectiveness of different modifications on thermal stability and then expressed and purified the most stable constructs.
Expression of these constructs in large-scale mammalian cell suspension cultures provided multi-milligram amounts of a stable locked open channel conformation that was fully active with unaltered channel parameters after reconstitution into proteoliposomes.
The availability of these and related stable preparations enable the initiation of studies of 3D structure and the binding of modulating small molecules.
Acknowledgments
Support of this work was by grants from the NIH, RO1-DK051870 and PO1-HL10873 and the Cystic Fibrosis Foundation. We thank Christie Broulliette for providing purified P-glycoprotein.
Abbreviations used
- CFTR
cystic fibrosis transmembrane conductance regulator
- ABC
ATP-binding cassette
- NBD1
N-terminal nucleotide-binding domain
- CF
cystic fibrosis
- CHO
Chinese hamster ovary
- HEK
human embryonic kidney
- BHK
baby hamster kidney
- Tm
melting temperature
- Ti
inactivation temperature
- RI
Regulatory Insertion (residues 404 – 435)
- 2PT
variant with NBD1 mutations S492P, A534P and I539T
- Q loop
residues contacting the gamma-phosphate of ATP
- SDR
structurally divers region
- DMNG
Decyl Maltose Neopentyl Glycol
- MALS
multi-angle light scattering analysis
- DOPE
1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine
- DOPC
1,2-Dioleoyl-sn-glycero-3-phosphocholine
- DOPS
1,2-dioleoyl-sn-glycero-3-phospho-L-serine
- SUV
small unilamellar vesicles
- LMV
large multilamellar vesicles
- LULV
large unilamellar vesicles
- PKA
protein kinase A
- RIPA
radioimmunoprecipitation assay
- ER
endoplasmic reticulum
- RAMP
gradual increase with constant slope
Footnotes
Conflict of Interest
None
Author contributions
LAA purified and reconstituted the stabilized CFTR; TJ developed suspension cell cultures and isolated CFTR containing membranes from them; LC designed, constructed and transfected cDNA plasmids; JNK maintained and harvested large scale CFTR expressing cell cultures; LH contributed to design and construction of mutant constructs; AAA performed all CFTR ion channel assays and measured their thermal stability; JRR wrote the manuscript
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Hunt JF, Wang C, Ford RC. Cystic fibrosis transmembrane conductance regulator (ABCC7) structure. Cold Spring Harb Perspect Med. 2013;3:a009514. doi: 10.1101/cshperspect.a009514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dawson RJ, Locher KP. Structure of a bacterial multidrug ABC transporter. Nature. 2006;443:180–185. doi: 10.1038/nature05155. [DOI] [PubMed] [Google Scholar]
- 3.Ward A, Reyes CL, Yu J, Roth CB, Chang G. Flexibility in the ABC transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci U S A. 2007;104:19005–19010. doi: 10.1073/pnas.0709388104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science (New York, NY) 2009;323:1718–1722. doi: 10.1126/science.1168750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jin MS, Oldham ML, Zhang Q, Chen J. Crystal structure of the multidrug transporter Pglycoprotein from Caenorhabditis elegans. Nature. 2012;490:566–569. doi: 10.1038/nature11448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Shintre CA, Pike AC, Li Q, Kim JI, Barr AJ, Goubin S, Shrestha L, Yang J, Berridge G, Ross J, Stansfeld PJ, Sansom MS, Edwards AM, Bountra C, Marsden BD, von Delft F, Bullock AN, Gileadi O, Burgess-Brown NA, Carpenter EP. Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states. Proc Natl Acad Sci U S A. 2013;110:9710–9715. doi: 10.1073/pnas.1217042110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lee JY, Yang JG, Zhitnitsky D, Lewinson O, Rees DC. Structural basis for heavy metal detoxification by an Atm1-type ABC exporter. Science (New York, NY) 2014;343:1133–1136. doi: 10.1126/science.1246489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kodan A, Yamaguchi T, Nakatsu T, Sakiyama K, Hipolito CJ, Fujioka A, Hirokane R, Ikeguchi K, Watanabe B, Hiratake J, Kimura Y, Suga H, Ueda K, Kato H. Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog. Proc Natl Acad Sci U S A. 2014;111:4049–4054. doi: 10.1073/pnas.1321562111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Srinivasan V, Pierik AJ, Lill R. Crystal structures of nucleotide-free and glutathionebound mitochondrial ABC transporter Atm1. Science (New York, NY) 2014;343:1137–1140. doi: 10.1126/science.1246729. [DOI] [PubMed] [Google Scholar]
- 10.Chang XB, Kartner N, Seibert FS, Aleksandrov AA, Kloser AW, Kiser GL, Riordan JR. Heterologous expression systems for study of cystic fibrosis transmembrane conductance regulator. Methods in enzymology. 1998;292:616–629. doi: 10.1016/s0076-6879(98)92048-1. [DOI] [PubMed] [Google Scholar]
- 11.Bear CE, Li C, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M, Riordan JR. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) Cell. 1992;68:809–818. doi: 10.1016/0092-8674(92)90155-6. [DOI] [PubMed] [Google Scholar]
- 12.Li C, Ramjeesingh M, Wang W, Garami E, Hewryk M, Lee D, Rommens JM, Galley K, Bear CE. ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1996;271:28463–28468. doi: 10.1074/jbc.271.45.28463. [DOI] [PubMed] [Google Scholar]
- 13.Ramjeesingh M, Li C, Garami E, Huan LJ, Hewryk M, Wang Y, Galley K, Bear CE. A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR) The Biochemical journal. 1997;327(Pt 1):17–21. doi: 10.1042/bj3270017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.NC, VK, TR, LA, JRR, RCF, Al-Zahrani Ateeq. Structure of the cystic fibrosis transmembrane conductance regulator in the inward-facing conformation revealed by single particle electron microscopy. AIMS Biophysics. 2015;2:131–152. [Google Scholar]
- 15.Kiser GL, Gentzsch M, Kloser AK, Balzi E, Wolf DH, Goffeau A, Riordan JR. Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae. Arch Biochem Biophys. 2001;390:195–205. doi: 10.1006/abbi.2001.2385. [DOI] [PubMed] [Google Scholar]
- 16.Tabcharani JA, Chang XB, Riordan JR, Hanrahan JW. Phosphorylation-regulated Clchannel in CHO cells stably expressing the cystic fibrosis gene. Nature. 1991;352:628–631. doi: 10.1038/352628a0. [DOI] [PubMed] [Google Scholar]
- 17.O’Riordan CR, Erickson A, Bear C, Li C, Manavalan P, Wang KX, Marshall J, Scheule RK, McPherson JM, Cheng SH, et al. Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells. J Biol Chem. 1995;270:17033–17043. doi: 10.1074/jbc.270.28.17033. [DOI] [PubMed] [Google Scholar]
- 18.Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR, Grinstein S. Confirmational maturation of CFTR but not its mutant counterpart (DF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 1994;13:6076–6086. doi: 10.1002/j.1460-2075.1994.tb06954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rosenberg MF, Kamis AB, Aleksandrov LA, Ford RC, Riordan JR. Purification and Crystallization of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) J Biol Chem. 2004;279:39051–39057. doi: 10.1074/jbc.M407434200. [DOI] [PubMed] [Google Scholar]
- 20.Hildebrandt E, Ding H, Mulky A, Dai Q, Aleksandrov AA, Bajrami B, Diego PA, Wu X, Ray M, Naren AP, Riordan JR, Yao X, DeLucas LJ, Urbatsch IL, Kappes JC. A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface. Molecular biotechnology. 2015;57:391–405. doi: 10.1007/s12033-014-9830-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhang L, Aleksandrov LA, Zhao Z, Birtley JR, Riordan JR, Ford RC. Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. Journal of structural biology. 2009;167:242–251. doi: 10.1016/j.jsb.2009.06.004. [DOI] [PubMed] [Google Scholar]
- 22.Chang XB, Tabcharani JA, Hou YX, Jensen TJ, Kartner N, Alon N, Hanrahan JW, Riordan JR. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all ten PKA consensus phosphorylation sites. J Biol Chem. 1993;268:11304–11311. [PubMed] [Google Scholar]
- 23.Kartner N, Augustinas O, Jensen TJ, Naismith AL, Riordan JR. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nature Genetics. 1992;1:321–327. doi: 10.1038/ng0892-321. [DOI] [PubMed] [Google Scholar]
- 24.Aleksandrov AA, Kota P, Cui L, Jensen T, Alekseev AE, Reyes S, He L, Gentzsch M, Aleksandrov LA, Dokholyan NV, Riordan JR. Allosteric modulation balances thermodynamic stability and restores function of DeltaF508 CFTR. J Mol Biol. 2012;419:41–60. doi: 10.1016/j.jmb.2012.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aleksandrov AA, Cui L, Riordan JR. Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator. J Physiol. 2009;587:2875–2886. doi: 10.1113/jphysiol.2009.170258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Aleksandrov AA, Riordan JR. Regulation of CFTR ion channel gating by MgATP. FEBS letters. 1998;431:97–101. doi: 10.1016/s0014-5793(98)00713-3. [DOI] [PubMed] [Google Scholar]
- 27.Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992;358:761–764. doi: 10.1038/358761a0. [DOI] [PubMed] [Google Scholar]
- 28.Hegedus T, Aleksandrov A, Cui L, Gentzsch M, Chang XB, Riordan JR. F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. Biochimica et biophysica acta. 2006;1758:565–572. doi: 10.1016/j.bbamem.2006.03.006. [DOI] [PubMed] [Google Scholar]
- 29.Liu X, O’Donnell N, Landstrom A, Skach WR, Dawson DC. Thermal instability of DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity. Biochemistry. 2012;51:5113–5124. doi: 10.1021/bi300018e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Protasevich I, Yang Z, Wang C, Atwell S, Zhao X, Emtage S, Wetmore D, Hunt JF, Brouillette CG. Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci. 2010;19:1917–1931. doi: 10.1002/pro.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wang C, Protasevich I, Yang Z, Seehausen D, Skalak T, Zhao X, Atwell S, Spencer Emtage J, Wetmore DR, Brouillette CG, Hunt JF. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis. Protein Sci. 2010;19:1932–1947. doi: 10.1002/pro.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.He L, Aleksandrov AA, An J, Cui L, Yang Z, Brouillette CG, Riordan JR. Restoration of NBD1 Thermal Stability Is Necessary and Sufficient to Correct ΔF508 CFTR Folding and Assembly. J Mol Biol. 2015;427:106–120. doi: 10.1016/j.jmb.2014.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Aleksandrov AA, Kota P, Aleksandrov LA, He L, Jensen T, Cui L, Gentzsch M, Dokholyan NV, Riordan JR. Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. J Mol Biol. 2010;401:194–210. doi: 10.1016/j.jmb.2010.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zaitseva J, Jenewein S, Jumpertz T, Holland IB, Schmitt L. H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB. The EMBO journal. 2005;24:1901–1910. doi: 10.1038/sj.emboj.7600657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Wolff S, Weissman JS, Dillin A. Differential scales of protein quality control. Cell. 2014;157:52–64. doi: 10.1016/j.cell.2014.03.007. [DOI] [PubMed] [Google Scholar]
- 36.Kopito RR. Biosynthesis and degradation of CFTR. Physiol Rev. 1999;79:S167–173. doi: 10.1152/physrev.1999.79.1.S167. [DOI] [PubMed] [Google Scholar]
- 37.Privalov PL, Dragan AI. Microcalorimetry of biological macromolecules. Biophysical chemistry. 2007;126:16–24. doi: 10.1016/j.bpc.2006.05.004. [DOI] [PubMed] [Google Scholar]
- 38.Privalov PL. Microcalorimetry of proteins and their complexes. Methods in molecular biology (Clifton, NJ) 2009;490:1–39. doi: 10.1007/978-1-59745-367-7_1. [DOI] [PubMed] [Google Scholar]